Table 1 Patient demographics and presentation during Period 1 (prepandemic) and Period 2 (pandemic period).
Variable | Period 1 (N = 762) | Period 2 (N = 478) | P Value |
|---|---|---|---|
Age (years) | 72.3 ± 16.2 | 65.1 ± 10.9 | < 0.001 |
Sex (M:F) | 543:219 | 306:172 | 0.008 |
Smoker, n (%) | 625 (82) | 358 (75) | 0.003 |
DM, n (%) | 442 (58) | 306 (64) | 0.035 |
CAD, n (%) | 236 (31) | 163 (34) | 0.251 |
Stroke, n (%) | 84 (11) | 39 (8) | 0.101 |
Hypertension, n (%) | 594 (78) | 387 (81) | 0.205 |
Hypercholesterolemia, n (%) | 381 (50) | 258 (54) | 0.178 |
Renal impairment, n (%) | 69 (9) | 81 (17) | < 0.001 |
Clinical presentation, n (%) | |||
Claudication | 236 (31) | 38 (8) | < 0.001 |
ALI | 91 (12) | 86 (18) | 0.003 |
CLTI | 411 (54) | 334 (70) | < 0.001 |
Others | 24 (3) | 20 (4) | 1 |
DFI | 220 (29) | 224 (47) | < 0.001 |
Rutherford categories of CLTI, n (%) | < 0.001 | ||
3–4 | 289 (38) | 100 (21) | |
5 | 381 (50) | 272 (57) | |
6 | 92 (12) | 106 (22) | |
Registration of critical lesion(s), n (%) | |||
Iliac | 137 (18) | 63 (13) | 0.471 |
Femoro-popliteal | 274 (36) | 191 (40) | 0.156 |
Infra-popliteal | 167 (22) | 133 (28) | 0.018 |
Multi-level | 184 (24) | 91 (19) | 0.895 |
WIfI mean score, n (%) | 0.009 | ||
0–1 | 175 (23) | 86 (18) | |
2 | 458 (60) | 254 (53) | |
3 | 129 (17) | 138 (29) | |
